Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study

被引:203
作者
Baba, Toru
Kikuchi, Akio
Hirayama, Kazumi [2 ,3 ]
Nishio, Yoshiyuki [2 ]
Hosokai, Yoshiyuki [2 ]
Kanno, Shigenori [2 ]
Hasegawa, Takafumi
Sugeno, Naoto
Konno, Masatoshi
Suzuki, Kyoko [2 ,4 ]
Takahashi, Shoki [5 ]
Fukuda, Hiroshi [6 ]
Aoki, Masashi
Itoyama, Yasuto [7 ]
Mori, Etsuro [2 ]
Takeda, Atsushi [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Neurol, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ, Grad Sch Med, Dept Behav Neurol & Cognit Neurosci, Sendai, Miyagi 9808574, Japan
[3] Yamagata Prefectural Univ Hlth Sci, Dept Occupat Therapy, Yamagata 9902212, Japan
[4] Yamagata Univ, Grad Sch Med Sci, Dept Clin Neurosci, Yamagata 9909585, Japan
[5] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Sendai, Miyagi 9808574, Japan
[6] Tohoku Univ, Inst Dev Ageing & Canc, Dept Nucl Med & Radiol, Sendai, Miyagi 9808574, Japan
[7] Natl Ctr Hosp, Tokyo 1878551, Japan
关键词
Parkinson's disease; dementia; olfaction; PET imaging; voxel-based morphometry; MILD COGNITIVE IMPAIRMENT; CEREBRAL GLUCOSE-METABOLISM; SMELL IDENTIFICATION; LEWY BODIES; PATHOLOGY; PROGRESSION; DEFICITS; AMYGDALA; CORTEX; SCALE;
D O I
10.1093/brain/awr321
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Dementia is one of the most debilitating symptoms of Parkinson's disease. A recent longitudinal study suggests that up to 80% of patients with Parkinson's disease will eventually develop dementia. Despite its clinical importance, the development of dementia is still difficult to predict at early stages. We previously identified olfactory dysfunction as one of the most important indicators of cortical hypometabolism in Parkinson's disease. In this study, we investigated the possible associations between olfactory dysfunction and the risk of developing dementia within a 3-year observation period. Forty-four patients with Parkinson's disease without dementia underwent the odour stick identification test for Japanese, memory and visuoperceptual assessments, F-18-fluorodeoxyglucose positron emission tomography scans and magnetic resonance imaging scans at baseline and 3 years later. A subgroup of patients with Parkinson's disease who exhibited severe hyposmia at baseline showed more pronounced cognitive decline at the follow-up survey. By the end of the study, 10 of 44 patients with Parkinson's disease had developed dementia, all of whom had severe hyposmia at baseline. The multivariate logistic analysis identified severe hyposmia and visuoperceptual impairment as independent risk factors for subsequent dementia within 3 years. The patients with severe hyposmia had an 18.7-fold increase in their risk of dementia for each 1 SD (2.8) decrease in the score of odour stick identification test for Japanese. We also found an association between severe hyposmia and a characteristic distribution of cerebral metabolic decline, which was identical to that of dementia associated with Parkinson's disease. Furthermore, volumetric magnetic resonance imaging analyses demonstrated close relationships between olfactory dysfunction and the atrophy of focal brain structures, including the amygdala and other limbic structures. Together, our findings suggest that brain regions related to olfactory function are closely associated with cognitive decline and that severe hyposmia is a prominent clinical feature that predicts the subsequent development of Parkinson's disease dementia.
引用
收藏
页码:161 / 169
页数:9
相关论文
共 42 条
[1]
The epidemiology of dementia associated with Parkinson disease [J].
Aarsland, Dag ;
Kurz, Martin Wilhelm .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2010, 289 (1-2) :18-22
[2]
Do parkinsonian patients have trouble telling lies The neurobiological basis of deceptive behaviour [J].
Abe, Nobuhito ;
Fujii, Toshikatsu ;
Hirayama, Kazumi ;
Takeda, Atsushi ;
Hosokai, Yoshiyuki ;
Ishioka, Toshiyuki ;
Nishio, Yoshiyuki ;
Suzuki, Kyoko ;
Itoyama, Yasuto ;
Takahashi, Shoki ;
Fukuda, Hiroshi ;
Mori, Etsuro .
BRAIN, 2009, 132 :1386-1395
[3]
Unified segmentation [J].
Ashburner, J ;
Friston, KJ .
NEUROIMAGE, 2005, 26 (03) :839-851
[4]
A fast diffeomorphic image registration algorithm [J].
Ashburner, John .
NEUROIMAGE, 2007, 38 (01) :95-113
[5]
Association of Olfactory Dysfunction and Brain. Metabolism in Parkinson's Disease [J].
Baba, Toru ;
Takeda, Atsushi ;
Kikuchi, Akio ;
Nishio, Yoshiyuki ;
Hosokai, Yoshiyuki ;
Hirayama, Kazumi ;
Hasegawa, Takafumi ;
Sugeno, Naoto ;
Suzuki, Kyoko ;
Mori, Etsuro ;
Takahashi, Shoki ;
Fukuda, Hiroshi ;
Itoyama, Yasuto .
MOVEMENT DISORDERS, 2011, 26 (04) :621-628
[6]
Inherent abnormalities in energy metabolism in Alzheimer disease - Interaction with cerebrovascular compromise [J].
Blass, JP ;
Sheu, RKF ;
Gibson, GE .
VASCULAR FACTORS IN ALZHEIMER'S DISEASE, 2000, 903 :204-221
[7]
Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease [J].
Bohnen, Nicolaas I. ;
Mueller, Martijn L. T. M. ;
Kotagal, Vikas ;
Koeppe, Robert A. ;
Kilbourn, Michael A. ;
Albin, Roger L. ;
Frey, Kirk A. .
BRAIN, 2010, 133 :1747-1754
[8]
AMYGDALA PATHOLOGY IN PARKINSONS-DISEASE [J].
BRAAK, H ;
BRAAK, E ;
YILMAZER, D ;
DEVOS, RAI ;
JANSEN, ENH ;
BOHL, J ;
JELLINGER, K .
ACTA NEUROPATHOLOGICA, 1994, 88 (06) :493-500
[9]
Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies [J].
Burn, DJ ;
Rowan, EN ;
Allan, LM ;
Molloy, S ;
T O'Brien, J ;
McKeith, IG .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (05) :585-589
[10]
Defining mild cognitive impairment in Parkinson's disease [J].
Caviness, John N. ;
Driver-Dunckley, Erika ;
Connor, Donald J. ;
Sabbagh, Marwan N. ;
Hentz, Joseph G. ;
Noble, Brie ;
Evidente, Virgilio Gerald H. ;
Shill, Holly A. ;
Adler, Charles H. .
MOVEMENT DISORDERS, 2007, 22 (09) :1272-1277